BSE Live
Apr 13, 16:01Prev. Close
57.09
Open Price
58.51
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Cash Flow of Aspira Pathlab & Diagnostics (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -4.24 | -5.17 | -5.58 | -2.72 | 0.04 | |
| Net CashFlow From Operating Activities | -1.87 | -3.39 | -4.81 | -1.29 | -0.37 | |
| Net Cash Used In Investing Activities | 0.24 | -1.97 | -0.77 | -10.14 | -0.02 | |
| Net Cash Used From Financing Activities | 1.27 | 3.35 | 6.52 | 8.91 | 2.64 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.35 | -2.00 | 0.94 | -2.52 | 2.25 | |
| Cash And Cash Equivalents Begin of Year | -1.87 | 0.14 | -0.80 | 5.33 | 3.08 | |
| Cash And Cash Equivalents End Of Year | -2.22 | -1.87 | 0.14 | 2.81 | 5.33 |
25.02.2026
Aspira Pathlab Standalone December 2025 Net Sales at Rs 5.12 crore, down 5.34% Y-o-Y
13.08.2025
Aspira Pathlab Consolidated June 2025 Net Sales at Rs 5.25 crore, up 13.17% Y-o-Y
19.05.2025
Aspira Pathlab Standalone March 2025 Net Sales at Rs 5.78 crore, up 51.31% Y-o-Y
10.02.2025
Aspira Pathlab Standalone December 2024 Net Sales at Rs 5.41 crore, up 56.21% Y-o-Y